Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Molecular Transport Inc
(NQ:
AMTI
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EST, Dec 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Applied Molecular Transport Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 17, 2023
Via
Benzinga
Applied Molecular: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Applied Molecular Transport Reports First Quarter 2023 Financial Results
May 11, 2023
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
3 Analysts Have This to Say About Applied Molecular
March 28, 2023
Via
Benzinga
Expert Ratings for Applied Molecular
March 06, 2023
Via
Benzinga
What To Know About SVB Leerink's Downgrade of Applied Molecular
December 27, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 27, 2022
December 27, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023
March 28, 2023
Via
Benzinga
Applied Molecular Transport Announces Corporate Leadership Change and Process to Explore Strategic Alternatives
March 27, 2023
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
Applied Molecular Transport Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 09, 2023
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
Applied Molecular Transport Presents Additional Data from Oral AMT-101 Phase 2 FILLMORE Trial in Chronic Pouchitis at ECCO ’23 Congress
March 03, 2023
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
February 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2023
February 08, 2023
Via
Benzinga
Applied Molecular Transport To $2? Here Are Other Price Target Changes For Tuesday
December 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 26, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 26, 2022
Via
Benzinga
Dow Rises 150 Points; Mission Produce Shares Slide
December 23, 2022
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday.
Via
Benzinga
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
December 23, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 23, 2022
Via
Benzinga
Dow Surges Over 100 Points; Crude Oil Rises Sharply
December 23, 2022
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 100 points on Friday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 23, 2022
December 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 23, 2022
Via
Benzinga
Applied Molecular's Ulcerative Colitis Candidate Fails To Separate From Placebo In Untreated Patients
December 23, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
OnFriday, 143 stocks hit new 52-week lows.
Via
Benzinga
Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
December 22, 2022
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.